Idea Innovative Drug European Associates Limited
02935871
Healthy
No risk factors detected.
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 06/06/1994
MANAGING DIRECTOR
GERMAN · GERMANY · Age 70
Persons with Significant Control
Harrison Life Sciences Group
C/O Blanche & Co, 3 The Lanterns, Royston, SG8 7BX
Reg: 08488903 · Companies House · Limited Company
Notified 06/04/2016
CompanyRankvs 503+ SIC 70229 peers89
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2024
Net Worth
£379k
Balance sheet strength
Cash
£121k
Cash in the bank
Net Current Assets
£377k
Working capital
Current Assets
£406k
Current Liabilities
£29k
Fixed Assets
£2k
Debtors
£285k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 14.16 | -£56k |
| 2023 | 11.99 | -£164k |
| 2022 | 10.00 | -£42k |
| 2021 | 11.01 | +£180k |
| 2019 | 10.63 | +£67k |
| 2018 | 9.28 | — |
Derived from filed accounts. Not audited figures.